Otwarty dostęp

Risk factors for osteoporosis in postmenopausal women – from the point of view of primary care gynecologist


Zacytuj

Figure 1

The questionnaire to obtain demographic,
anthropometric, and fracture data, and the risk factors for OP.
The questionnaire to obtain demographic, anthropometric, and fracture data, and the risk factors for OP.

Figure 2

The incidence of osteoporosis concerning HT use (N=2956).
The incidence of osteoporosis concerning HT use (N=2956).

Figure 3

The use of anti-resorptive therapy by age groups (N=1274).
The use of anti-resorptive therapy by age groups (N=1274).

General characteristics of the women (n=2956).

N

Some data were missing, hence differences in totals

Min.Max.Mean ± SD
Age (years)2810199861.0 ± 11.0
Age at onset of menopause (years)2486206449.0 ± 4.7
Weight (kg)29423516471.0 ± 12.9
Height before measurement2299135182162.3 ± 5.9
on measurement (cm)2906129180158.8 ± 6.3
Body mass index (BMI)289616.046.028.1 ± 4.9

Odds ratio for osteoporosis concerning risk factors (N=1274) (univariate and multivariate regression).

OR (95%CI) univariateOR (95%CI) multivariate
Age1.07 (1.04 - 1.11) p<0.0011.08 (1.05 - 1.11) p<0.001
BMI 18.5-25 (ref)1 (ref)1 (ref)
BMI<18.51.86 (0.35 - 9.8) p=0.4622.32 (0.40 - 13.5) p=0.350
BMI=25-300.37 (0.27 - 0.52) p<0.0010.38 (0.27 - 0.54) p<0.001
BMI=30-350.19 (0.13 - 0.28) p<0.0010.19 (0.13 - 0.27) p<0.001
BMI= > 350.12 (0.07 - 0.20) p<0.0010.11 (0.07 - 0.19) p<0.001
Non-smoker0.42 (0.24 - 0.74) p=0.0020.55 (0.29 - 1.01) p=0.055
Hormone contraception (ever user)1.02 (0.77 - 1.36) p=0.8641.15 (0.84 - 1.59) p=0.373
HT (ever user)0.31 (0.13 - 0.73) p=0.0080.26 (0.10 - 0.65) p=0.004
Height loss >3 cm1.11 (0.87 - 1.41) p=0.3921.13 (0.86 - 1.47) p= 0.377

The prevalence of osteoporosis and fracture risk factors regarding age (N=1274).

60-64 years (N=460)65-69 years (N=370)70-75 years (N=444)p-value
Osteoporosis prevalence132 (24.9%)102 (34.2%)166 (37.4%)<0.001

Chi-square for linear association

Low calcium intake46 (10.0%)38 (10.3%)60 (13.5%)0.097

Chi-square for linear association

Observed height loss in cm (SD)2.57 (2.4)3.05 (2.8)4.30 (3.9)< 0.001

Spearman correlation

Smokers25 (5.4%)15 (4.1%)14 (3.2%)0.088

Chi-square for linear association

Osteoporotic fractures in the last 5 years72 (15.7%)80 (21.6%)114 (25.7%)< 0.001

Chi-square for linear association

Wrist fracture31 (6.7%)40 (10.8%)57 (12.8%)0.002

Chi-square for linear association

Hip fracture5 (1.1%)9 (2.4%)20 (4.5%)0.001

Chi-square for linear association

Corticosteroid use15 (3.3%)23 (6.2%)18 (4.1%)0.107

Chi-square

BMC (g/cm2) - L1-L454.0 (11.5)52.9 (12.9)51.1 (11.6)0.001

Spearman correlation

BMC (g/cm2) - hip31.1 (5.8)30.4 (6.2)29.3 (5.7)< 0.001

Spearman correlation

Family history of osteoporosis58 (12.6%)38 (10.3%)49 (11.0%)0.551

Chi-square

eISSN:
1854-2476
Język:
Angielski
Częstotliwość wydawania:
4 razy w roku
Dziedziny czasopisma:
Medicine, Clinical Medicine, Hygiene and Environmental Medicine